# WhitePact Enterprise Neural — Progress Ledger

Permanent, version-controlled record of phase status for the Enterprise
Neural directive. Updated at the end of every phase. Never mark PASS
without evidence (test output, file paths, commit SHA).

| Phase | Name | Status | Commit | Test Result | Security Result | Residual Risk |
|---|---|---|---|---|---|---|
| 0 | Security Constitution + Current-State Audit | **PASS** (foundation track) | uncommitted | N/A (audit only, no code) | N/A | Neural/BCI track has zero existing code — treated as separate go/no-go, not yet started (see report §7) |
| 1 | Secure SDLC + Software Supply Chain | **PASS** — all 12 PR #50 checks green, CodeQL 0 findings verified via API | dd070de (PR #50, unmerged — cumulative review branch) | All checks pass | CodeQL: 0 open alerts. All required gates (CI, CodeQL, dependency-review, Gitleaks, DCO) green. | Container/IaC scanning still absent; `required_approving_review_count: 0` accepted as founder-led-project reality, not fixed |
| 2 | Cryptographic Foundation + Key Management | **PASS — all 5/5 implementation steps complete.** Design audit PASS; Steps 1-5 PASS. See `02_PHASE2_STEP5_REPORT.md`'s final verdict: real, tested key-management foundation delivered and wired into field encryption + SAML session signing; webhook signing correctly excluded (two-party secret, see Step 4); **not yet activated in any running deployment** — app-startup wiring remains a separate, unscheduled step | pending (uncommitted at ledger update time) | 100/100 new tests pass (Steps 1-5 combined), 100% coverage on all directly-covered modules; full suite 2965 passed, 0 failed | 8 real bugs found and fixed pre-commit across Steps 1-3 and 5 (KeyId sentinel collision, version-numbering overwrite, LocalEnvelopeKeyProvider.store type over-narrowing, TOTP/base64 format-detection collision, decode_envelope lenient decoding, legacy-ciphertext double-wrapping in the rotation script) plus 1 design correction (Step 4, webhook signing scope) | Application-startup wiring absent across all call sites — this is Phase 2's single largest residual risk, spanning every step's report; webhook secret rotation remains unsolved by design (needs a different, receiver-coordinated approach, out of this phase's scope) |
| 3 | Zero-Trust Identity + Tenant Isolation | NOT STARTED (merges with `docs/heart-production/` Phase 3+) | — | — | — | — |
| 4 | Neural Data Privacy Architecture | **PASS — functionally complete for what can be built without a device adapter.** Design PASS, Step 1/2 PASS (classification vocabulary + fail-closed consent policy), Step 2/2 PASS (Neural Vault persistence, migration `0031`). Retention-expiry enforcement, export endpoint, and end-to-end leakage tests remain, blocked on Phase 5 (real BCI data to test against) | pending (uncommitted at ledger update time) | 43/43 new tests pass (Steps 1-2 combined), 100% coverage; full suite 3009 passed, 0 failed | No bugs this phase — one routine test-value update (test_db_migrate.py head revision) | No application code path reaches this layer yet (same as every phase so far); `encrypted_sync_copy` has no writer; recommend proceeding to Phase 5 next |
| 5 | Universal BCI Device + Trust Layer | **PASS — scoped to the typed contract, deliberately no BrainFlow/LSL/vendor dependency and no concrete adapter** (no real device to validate against — see `05_PHASE5_REPORT.md` Scope decision) | pending (uncommitted at ledger update time) | 18/18 new tests pass, 100% coverage; full suite 3028 passed, 0 failed | No bugs this phase | No concrete `BCIDeviceAdapter` implementation exists; Protocol shape unvalidated against a real SDK until a vendor decision is made |
| 6 | Neural Signal Integrity + Decoder Safety | **PASS — scoped to the typed `NeuralDecision` contract, deliberately no decoder** (no real trained model or device signal to validate against) | pending (uncommitted at ledger update time) | 40/40 new tests pass, 100% coverage; full suite 3069 passed, 0 failed | No bugs this phase | No decoder exists; thresholds in `classify_decision_status` are caller-supplied placeholders, unvalidated against a real decoder |
| 7 | Neural Intent Attestation + Action Binding | **PASS — fully implemented and tested, unlike 5/6** (attestation is a pure transformation over typed objects, not hardware/model-dependent). Mutation-invalidates-authorization property implemented literally and tested against the directive's own ₹1,000→₹100,000 / recipient-A→B examples | pending (uncommitted at ledger update time) | 24/24 new tests pass, 100% coverage; full suite 3095 passed, 0 failed | No bugs in shipped code; one test-authoring mistake (`dataclasses.asdict` on a nested-dataclass object) caught and fixed before commit | No persistence layer; attestation replay-before-expiry (same token used twice) not addressed — that's a future execution-permit (single-use consumption) concern, not this phase's scope |
| 8 | LLM + Agent Security Boundary | **PASS — audit-driven, not a rebuild.** Most requirements already held structurally (prior Heart/Production-Integration work); this phase adds regression-tested evidence, not new architecture. Two real gaps named explicitly: stdio transport ungoverned, no tool-argument schema validation — both correctly out of scope | pending (uncommitted at ledger update time) | 7/7 new tests pass; full suite 3102 passed, 0 failed | No bugs in shipped code; 3 test field-name mistakes caught and fixed before first run by reading `governance/models.py` directly | Stdio transport ungoverned (pre-existing, self-documented); no LLM tool-argument schema validation — both flagged as separate future initiatives |
| 9 | Heart Production Authority Integration | NOT STARTED — this is `docs/heart-production/` Phases 3–20, resumed there | — | — | — | — |
| 10 | Brain Policy + Risk Engine | NOT STARTED | — | — | — | — |
| 11 | Citadel Execution Containment | NOT STARTED | — | — | — | — |
| 12 | Platform + Network + Service Isolation | NOT STARTED | — | — | — | — |
| 13 | Immutable Audit + Evidence | NOT STARTED | — | — | — | — |
| 14 | Resilience + Fail-Closed Operations | NOT STARTED | — | — | — | — |
| 15 | Enterprise Trust + Procurement Readiness | NOT STARTED | — | — | — | — |
| 16 | Neural Scientific Evidence System | NOT STARTED — blocked with Phases 4–7 | — | — | — | — |
| 17 | Full Adversarial Hardening | NOT STARTED | — | — | — | — |
| 18 | Final Enterprise Release Verification | NOT STARTED | — | — | — | — |

**Note on Phases 4–7, 16 (the neural/BCI track):** Phase 0's audit found
zero existing neural/BCI code in the repository — these phases are a
distinct, large, net-new product initiative, not hardening. Explicit
go-ahead given to proceed through Phases 4–18 (excluding 3, tracked via
`docs/heart-production/`, and 9, deferred pending separate unsynced
Codex work on WhitePact) — work is now proceeding phase-by-phase with
the same design-then-implement-then-report rigor established in Phase 2.

**Note on Phase 9:** merged into the already-in-progress
`docs/heart-production/` initiative per your prior direction — tracked
there, not duplicated here.
